KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs Aug. 23, 2019 KNC Laboratories Co. Ltd. (TYO:6568) is moving to bolster its business in middle-molecule drugs. The company has developed a device…... Please subscribe to read the full story. Subscribe Free Trial